"id","description","identifier","instanceType","name","uuid:ID","label","text"
"EligibilityCriterion_1","The study age criterion","1","EligibilityCriterion","Age Criteria","15e23acf-41e9-4bfd-8e14-5c4c951f04df","","Subjects shall be between [min_age] and [max_age]"
"EligibilityCriterion_2","The study population criterion","2","EligibilityCriterion","Pop Criteria","5b303831-17aa-4051-8468-b6e1b018b227","","[StudyPopulation] as defined by the NINCDS and the ADRDA guidelines (Attachment LZZT.7)"
"EligibilityCriterion_3","The study diagnosis criterion","3","EligibilityCriterion","Diag Criteria","f361d397-0760-4fbf-a7bf-bad8d341f387","","[Activity1] score of 10 to 23"
"EligibilityCriterion_4","The previous xanomeline TTS criterion","9","EligibilityCriterion","Previous Criteria","4c3176e0-abd1-41fe-9d90-546b72386598","","Persons who have previously completed or withdrawn from this study or any other study investigating xanomeline TTS or the oral formulation of xanomeline."
